Center-Authored Papers

Filters: Author is Reding, Kerryn W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Reding KW, Daling JR, Doody DR, O'Brien CA, Porter PL, Malone KE.  2008.  Effect of prediagnostic alcohol consumption on survival after breast cancer in young women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(8):1988-96. Abstract
2009
Reding KW, Li CI, Weiss NS, Chen C, Carlson CS, Duggan D, Thummel KE, Daling JR, Malone KE.  2009.  Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.. American journal of epidemiology. 170(10):1241-9. Abstract
Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson H-W, Farin FM, Thummel KE, Daling JR, Malone KE.  2009.  Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1461-7. Abstract
2010
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN et al..  2010.  Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.. Breast cancer research and treatment. 123(2):491-8. Abstract
2011
Reding KW, Doody DR, McTiernan A, Hsu L, Davis S, Daling JR, Porter PL, Malone KE.  2011.  Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer.. Breast cancer research and treatment. 126(3):749-61. Abstract
Reding KW, Lampe JW, Wang C-Y, Stanczyk FZ, Ulrich CM, Xiao L, Duggan CR, McTiernan A.  2011.  A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations.. Cancer epidemiology. 35(6):569-73. Abstract
2012
Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK, Marchbanks PA, Bernstein L et al..  2012.  Estrogen-related genes and their contribution to racial differences in breast cancer risk.. Cancer causes & control : CCC. 23(5):671-81. Abstract
Reding KW, Carlson CS, Kahsai O, Chen CC, McDavid A, Doody DR, Chen C, Ornelas I, Lowe K, Bernstein L et al..  2012.  Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among black and white women.. Breast cancer research and treatment. Abstract
2014
Molina Y, Yi JC, Martinez-Gutierrez J, Reding KW, Yi-Frazier JP, Rosenberg AR.  2014.  Resilience among patients across the cancer continuum.. Clinical journal of oncology nursing. 18(1):93-101. Abstract
3-Hydroxysteroid Dehydrogenases
Reding KW, Li CI, Weiss NS, Chen C, Carlson CS, Duggan D, Thummel KE, Daling JR, Malone KE.  2009.  Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.. American journal of epidemiology. 170(10):1241-9. Abstract
Adult
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN et al..  2010.  Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.. Breast cancer research and treatment. 123(2):491-8. Abstract
Reding KW, Daling JR, Doody DR, O'Brien CA, Porter PL, Malone KE.  2008.  Effect of prediagnostic alcohol consumption on survival after breast cancer in young women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(8):1988-96. Abstract
Age Factors
Reding KW, Doody DR, McTiernan A, Hsu L, Davis S, Daling JR, Porter PL, Malone KE.  2011.  Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer.. Breast cancer research and treatment. 126(3):749-61. Abstract
Aged
Reding KW, Doody DR, McTiernan A, Hsu L, Davis S, Daling JR, Porter PL, Malone KE.  2011.  Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer.. Breast cancer research and treatment. 126(3):749-61. Abstract
Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson H-W, Farin FM, Thummel KE, Daling JR, Malone KE.  2009.  Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1461-7. Abstract
Reding KW, Li CI, Weiss NS, Chen C, Carlson CS, Duggan D, Thummel KE, Daling JR, Malone KE.  2009.  Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.. American journal of epidemiology. 170(10):1241-9. Abstract
Alcohol Drinking
Reding KW, Daling JR, Doody DR, O'Brien CA, Porter PL, Malone KE.  2008.  Effect of prediagnostic alcohol consumption on survival after breast cancer in young women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(8):1988-96. Abstract
Alleles
Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson H-W, Farin FM, Thummel KE, Daling JR, Malone KE.  2009.  Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1461-7. Abstract
Antineoplastic Combined Chemotherapy Protocols
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN et al..  2010.  Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.. Breast cancer research and treatment. 123(2):491-8. Abstract
Apr 2012
Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK, Marchbanks PA, Bernstein L et al..  2012.  Estrogen-related genes and their contribution to racial differences in breast cancer risk.. Cancer causes & control : CCC. 23(5):671-81. Abstract
April 2012
Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK, Marchbanks PA, Bernstein L et al..  2012.  Estrogen-related genes and their contribution to racial differences in breast cancer risk.. Cancer causes & control : CCC. 23(5):671-81. Abstract
Aryl Hydrocarbon Hydroxylases
Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson H-W, Farin FM, Thummel KE, Daling JR, Malone KE.  2009.  Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1461-7. Abstract
August 2012
Duggan C, Wang C-Y, Neuhouser ML, Xiao L, Smith AW, Reding KW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R et al..  2012.  Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer.. International journal of cancer. Journal international du cancer. Abstract
BRCA1 Protein
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN et al..  2010.  Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.. Breast cancer research and treatment. 123(2):491-8. Abstract
BRCA2 Protein
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN et al..  2010.  Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.. Breast cancer research and treatment. 123(2):491-8. Abstract